Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ACT NYSEARCA:BTEK NYSEARCA:MSOX NYSEARCA:PSIL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACTEnact$35.03-1.3%$35.81$30.79▼$37.97$5.32B0.58353,162 shs218,487 shsBTEKBlackRock Future Tech ETF$23.18$23.18$18.92▼$28.67$13.91M1.643,762 shsN/AMSOXAdvisorShares MSOX 2X Daily ETF$3.58+7.5%$2.98$2.14▼$61.60$14.96M3.97309,588 shs261,406 shsPSILAdvisorShares Psychedelics ETF$17.16+1.9%$14.30$7.14▼$17.23$12.87M0.9311,640 shs17,449 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACTEnact-1.27%-0.17%-6.44%+0.49%+3.92%BTEKBlackRock Future Tech ETF0.00%0.00%0.00%0.00%-9.70%MSOXAdvisorShares MSOX 2X Daily ETF+7.51%+18.54%+57.02%-14.96%-93.83%PSILAdvisorShares Psychedelics ETF+1.90%+10.71%+20.59%+46.92%+1,474.31%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACTEnactN/AN/AN/AN/AN/AN/AN/AN/ABTEKBlackRock Future Tech ETFN/AN/AN/AN/AN/AN/AN/AN/AMSOXAdvisorShares MSOX 2X Daily ETFN/AN/AN/AN/AN/AN/AN/AN/APSILAdvisorShares Psychedelics ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACTEnact 0.00N/AN/AN/ABTEKBlackRock Future Tech ETF 2.78Moderate Buy$23.18N/AMSOXAdvisorShares MSOX 2X Daily ETF 0.00N/AN/AN/APSILAdvisorShares Psychedelics ETF 2.93Moderate Buy$17.16N/ACurrent Analyst Ratings BreakdownLatest MSOX, BTEK, ACT, and PSIL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/11/2025ACTEnactJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$37.00 ➝ $39.007/7/2025ACTEnactKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetMarket Perform ➝ Market Perform$39.00 ➝ $40.005/5/2025ACTEnactUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$38.00 ➝ $40.005/5/2025ACTEnactKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Market Perform$39.00 ➝ $39.00(Data available from 7/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACTEnact$1.20B4.37$4.62 per share7.59$32.53 per share1.08BTEKBlackRock Future Tech ETFN/AN/AN/AN/AN/AN/AMSOXAdvisorShares MSOX 2X Daily ETFN/AN/AN/AN/AN/AN/APSILAdvisorShares Psychedelics ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACTEnact$688.07M$4.447.897.632.1756.93%14.44%11.01%7/30/2025 (Estimated)BTEKBlackRock Future Tech ETFN/AN/A42.91∞N/AN/AN/AN/AN/AMSOXAdvisorShares MSOX 2X Daily ETFN/AN/A0.00∞N/AN/AN/AN/AN/APSILAdvisorShares Psychedelics ETFN/AN/A0.00∞N/AN/AN/AN/AN/ALatest MSOX, BTEK, ACT, and PSIL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2025Q2 2025ACTEnact$1.15N/AN/AN/A$307.54 millionN/A4/30/2025Q1 2025ACTEnact$1.12$1.10-$0.02$1.08$302.28 million$306.78 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACTEnact$0.842.40%N/A18.92%3 YearsBTEKBlackRock Future Tech ETFN/A0.00%N/AN/AN/AMSOXAdvisorShares MSOX 2X Daily ETFN/A0.00%N/AN/AN/APSILAdvisorShares Psychedelics ETF$0.331.92%N/AN/AN/ALatest MSOX, BTEK, ACT, and PSIL DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/19/2025ACTEnactquarterly$0.212.35%5/19/20255/19/20256/11/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioACTEnact0.151.131.13BTEKBlackRock Future Tech ETFN/AN/AN/AMSOXAdvisorShares MSOX 2X Daily ETFN/AN/AN/APSILAdvisorShares Psychedelics ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACTEnact18.03%BTEKBlackRock Future Tech ETFN/AMSOXAdvisorShares MSOX 2X Daily ETFN/APSILAdvisorShares Psychedelics ETFN/AInsider OwnershipCompanyInsider OwnershipACTEnact0.44%BTEKBlackRock Future Tech ETFN/AMSOXAdvisorShares MSOX 2X Daily ETFN/APSILAdvisorShares Psychedelics ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACTEnact500150.07 million149.41 millionNot OptionableBTEKBlackRock Future Tech ETFN/A600,000N/ANot OptionableMSOXAdvisorShares MSOX 2X Daily ETFN/A4.18 millionN/ANot OptionablePSILAdvisorShares Psychedelics ETFN/A750,000N/ANot OptionableMSOX, BTEK, ACT, and PSIL HeadlinesRecent News About These Companies7 Best Psychedelic Stocks and ETFs to BuyJuly 18, 2025 | wtop.comWAdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Shares Up 3.1% - What's Next?July 17, 2025 | americanbankingnews.com5 ETFs That Beat the Market in the First Half of 2025June 20, 2025 | zacks.com5 Sector ETFs That Have Outperformed the S&P 500 in Q1March 27, 2025 | zacks.com5 Best-Performing Sector ETFs Halfway Through Q1February 20, 2025 | zacks.comWhen the Price of (PSIL) Talks, People ListenFebruary 12, 2025 | news.stocktradersdaily.comNHigh-Momentum ETFs Leading the Market This Year (PSIL)...February 7, 2025 | marketbeat.com5 Best-Performing Sector ETFs of Volatile JanuaryFebruary 3, 2025 | zacks.com5 Best-Performing ETFs of JanuaryJanuary 31, 2025 | zacks.comUnder-the-Radar Opportunities in ETFsJanuary 30, 2025 | etftrends.comEETF Prime: Islam Shares 2025's Top Trends and ETFsJanuary 28, 2025 | etftrends.comE5 Best-Performing Sector ETFs of Q4January 2, 2025 | zacks.com(PSIL) Technical DataJanuary 1, 2025 | news.stocktradersdaily.comNTrend Tracker for (PSIL)December 20, 2024 | news.stocktradersdaily.comN(PSIL) Proactive StrategiesDecember 10, 2024 | news.stocktradersdaily.comNNo Trippin’: Trump Trade Pushes PSIL, VCAR HigherNovember 15, 2024 | finance.yahoo.com5 Best-Performing Sector ETFs Midway in Q4November 15, 2024 | zacks.com5 Best-Performing ETFs of OctoberNovember 1, 2024 | zacks.comDRUG Enhances Buzz for Psilocybin, Psychedelic ETFsOctober 18, 2024 | finance.yahoo.comTop and Flop ETFs of the First Nine MonthsSeptember 30, 2024 | zacks.com(PSIL) Pivots Trading Plans and Risk ControlsSeptember 27, 2024 | news.stocktradersdaily.comNNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Catalysts Driving Plug Power’s Turnaround CaseBy Jeffrey Neal Johnson | July 18, 2025View 3 Catalysts Driving Plug Power’s Turnaround CaseAddition by Subtraction: Intel’s New Strategy Energizes InvestorsBy Jeffrey Neal Johnson | June 27, 2025View Addition by Subtraction: Intel’s New Strategy Energizes InvestorsTop 5 Stocks for July: Momentum-Driven Picks to Watch NowBy Thomas Hughes | June 30, 2025View Top 5 Stocks for July: Momentum-Driven Picks to Watch Now3 Notable Stocks Just Split: Which One Could Be the Big Winner?By Leo Miller | June 26, 2025View 3 Notable Stocks Just Split: Which One Could Be the Big Winner?Rocket Lab: Latest Catalysts Bolster the Bull CaseBy Ryan Hasson | July 3, 2025View Rocket Lab: Latest Catalysts Bolster the Bull CaseMSOX, BTEK, ACT, and PSIL Company DescriptionsEnact NASDAQ:ACT$35.03 -0.45 (-1.27%) Closing price 07/24/2025 04:00 PM EasternExtended Trading$35.02 -0.01 (-0.03%) As of 07/24/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Enact Holdings, Inc. operates as a private mortgage insurance company in the United States. It engages in writing and assuming residential mortgage guaranty insurance. The company also offers private mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; contract underwriting services for mortgage lenders; and mortgage-related reinsurance products. It primarily serves originators of residential mortgage loans. The company was formerly known as Genworth Mortgage Holdings, Inc. and changed its name to Enact Holdings, Inc. in May 2021. Enact Holdings, Inc. was founded in 1981 and is headquartered in Raleigh, North Carolina. Enact Holdings, Inc. operates as a subsidiary of Genworth Holdings Inc.BlackRock Future Tech ETF NYSEARCA:BTEK$23.18 0.00 (0.00%) As of 08/15/2024The BlackRock Future Tech ETF (BTEK) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities involved in the technology sector. BTEK was launched on Sep 29, 2020 and is managed by BlackRock.AdvisorShares MSOX 2X Daily ETF NYSEARCA:MSOX$3.58 +0.25 (+7.51%) Closing price 07/24/2025 04:10 PM EasternExtended Trading$3.60 +0.02 (+0.59%) As of 07/24/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Advisorshares Msos 2x Daily ETF (MSOX) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund-of-fund that seeks to achieve 2x the daily total return of the AdvisorShares Pure US Cannabis ETF (MSOS) through swap agreements. MSOX was launched on Aug 23, 2022 and is managed by AdvisorShares.AdvisorShares Psychedelics ETF NYSEARCA:PSIL$17.16 +0.32 (+1.90%) Closing price 07/24/2025 04:10 PM EasternExtended Trading$17.40 +0.24 (+1.40%) As of 07/24/2025 07:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Krispy Kreme: A Meme Stock Sugar Rush or a Sustainable Treat? From Zero to Hero? Why GoPro's Rally Could Be More Than It Seems A Smokin’ Hot Entry Point for Chipotle Stock Opens in Q3 Alphabet’s Breakout Quarter Signals a New Leadership Phase Tesla Just Hit a Fork in the Road—Could the Bulls Lose Control? GE Vernova's Q2 Electrifies Stock, What's Next For This Top Name? Is Former Dividend Aristocrat AT&T a Buy After Q2 Earnings? What's Behind Opendoor Technologies' Rally? Is Meme Mania Back? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
